Analysts from RHB Group Research and CGS-CIMB Research have given mixed reactions to UG Healthcare’s announcement on July 12 that it was halting operations of its manufacturing plants in Seremban temporarily due to Malaysia's Enhanced Movement Control Order (EMCO) from July 9 to July 22.

See also: UG Healthcare to see further 2.4% drop in glove production due to EMCO

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook